Shockwave Medical Announces U.S. Commercial Availability of Lithoplasty® System and Enrollment of First Patient in DISRUPT PAD III Global Clinical Trial
Novel Technology Uses Sonic Pressure Waves to Treat Peripheral Artery Blockages
Shockwave Medical, a pioneer in the treatment of calcified cardiovascular disease, today announced two milestones for its Lithoplasty® System for the treatment of calcified plaque in patients...
Shockwave Medical Announces CE Mark for Coronary Lithoplasty System and Activities at EuroPCR 2017
March 15, 2017
Shockwave Medical, a pioneer in the treatment of calcified cardiovascular disease, today announced conformité européenne (CE) Mark for the company’s Coronary Lithoplasty System for the treatment of calcified plaque in conjunction with stenting in patients...